LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
The new assets expand Biocon Biologics’ already robust oncology portfolio, which now includes 17 cancer therapies
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Puri is an accomplished leader and financial sector veteran with over four decades of experience
Subscribe To Our Newsletter & Stay Updated
